U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07794813) titled 'Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer' on July 31.
Brief Summary: Given the morphological and clinical similarities between certain oral malignant neoplasms and benign conditions such as oral ulcerations or inflammatory lesions, the potential for misdiagnosis is significant. Currently, histopathological examination via tissue biopsy remains the diagnostic gold standard; however, this approach is inherently invasive and may yield incomplete diagnostic results due to sampling limitations and spatial heterogeneity of the lesion. These challenges underscore the urgent need for the development of s...